Impact of Massage Therapy on Fatigue, Pain, and Spasticity in People with Multiple Sclerosis: a Pilot Study

Deborah Backus, Christine Manella, Anneke Bender, Mark Sweatman, Deborah Backus, Christine Manella, Anneke Bender, Mark Sweatman

Abstract

Background: Multiple sclerosis (MS) is a chronic, immune-mediated, inflammatory disease that leads to fatigue, pain, and spasticity, as well as other sensorimotor and cognitive changes. Often traditional medical approaches are ineffective in alleviating these disruptive symptoms. Although about one-third of surveyed individuals report they use massage therapy (MT) as an adjunct to medical treatment, there is little empirical evidence that MT is effective for symptom management in people with MS.

Purpose: To measure the effects of MT on fatigue, pain, spasticity, perception of health, and quality of life in people with MS.

Setting: Not-for-profit long-term care facility.

Participants: Twenty-four of 28 enrolled individuals with MS (average age = 47.38, SD = 13.05; 22 female) completed all MT sessions and outcome assessments.

Research design: Nonrandomized, pre-post pilot study.

Intervention: Standardized MT routine one time a week for six weeks.

Main outcome measures: Modified Fatigue Index Scale (MFIS), MOS Pain Effects Scale (MOS Pain), and Modified Ashworth Scale (MAS). Secondary outcome measures: Mental Health Inventory (MHI) and Health Status Questionnaire (HSQ).

Results: There was a significant improvement in MFIS (p < .01), MOS Pain (p < .01), MHI (p < .01), and HSQ (p < .01), all with a large effect size (ES) (Cohen's d = -0.76, 1.25, 0.93, -1.01, respectively). There was a significant correlation between change scores on the MFIS and the MOS Pain (r = 0.532, p < .01), MHI (r = -0.647, p < .01), and subscales of the HSQ (ranging from r = -0.519, to -0.619, p < .01).

Conclusions: MT as delivered in this study is a safe and beneficial intervention for management of fatigue and pain in people with MS. Decreasing fatigue and pain appears to correlate with improvement in quality of life, which is meaningful for people with MS who have a chronic disease resulting in long-term health care needs.

Keywords: fatigue; multiple sclerosis; pain; spasticity; symptom management; therapeutic massage.

Conflict of interest statement

NOTIFICATION This work was funded by the Massage Therapy Foundation. There are no other conflicts of interest for any of the authors.

References

    1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517. doi: 10.1016/S0140-6736(08)61620-7. .
    1. Frohman TC, Castro W, Shah A, Courtney A, Ortstadt J, Davis SL, et al. Symptomatic therapy in multiple sclerosis. Ther Adv Neurol Disord. 2011;4(2):83–98. doi: 10.1177/1756285611400658. .
    1. Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler. 2001;7(5):340–344. doi: 10.1191/135245801681138059. .
    1. Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci. 2002;205(1):51–58. doi: 10.1016/S0022-510X(02)00312-X. .
    1. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler. 2003;9(3):219–227. doi: 10.1191/1352458503ms904oa. .
    1. Schreurs KM, de Ridder DT, Bensing JM. Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression. J Psychosom Res. 2002;53(3):775–781. doi: 10.1016/S0022-3999(02)00326-4. .
    1. Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler. 2000;6(3):181–185. doi: 10.1191/135245800701566052. .
    1. Krupp LB. Fatigue in multiple sclerosis: definitions, pathophysiology, and treatment. CNS Drugs. 2003;17(4):225–234. doi: 10.2165/00023210-200317040-00002. .
    1. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci. 2006;243(1–2):39–45. doi: 10.1016/j.jns.2005.11.025. .
    1. Svendsen KB, Jensen TS, Overvad K, Hansen HJ, Koch-Henriksen N, Bach FW. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol. 2003;60(8):1089–1094. doi: 10.1001/archneur.60.8.1089. .
    1. Beiske AG, Pedersen ED, Czujko B, Myhr KM. Pain and sensory complaints in multiple sclerosis. Eur J Neurol. 2004;11(7):479–482. doi: 10.1111/j.1468-1331.2004.00815.x. .
    1. Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D’Aleo G, et al. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology. 2004;63(5):919–921. doi: 10.1212/01.WNL.0000137047.85868.D6. .
    1. Österberg A, Boivie J, Thuomas KÅ. Central pain in multiple sclerosis—prevalence and clinical characteristics. Eur J Pain. 2005;9(5):531–531. doi: 10.1016/j.ejpain.2004.11.005. .
    1. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004;10(5):589–595. doi: 10.1191/1352458504ms1085oa. .
    1. Barnes MP, Kent RM, Semlyen JK, McMullen KM. Spasticity in multiple sclerosis. Neurorehabil Neural Repair. 2003;17(1):66–70. doi: 10.1177/0888439002250449. .
    1. Beard SM, Hunn A, Wight J. Treatments for spasticity and pain in multiple sclerosis: a systematic review. 2003;7(40):1–111. .
    1. Kalia LV, O’Connor PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler. 2005;11(3):322–327. doi: 10.1191/1352458505ms1168oa. .
    1. Svendsen KB, Jensen TS, Hansen HJ, Bach FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain. 2005;114(3):473–481. doi: 10.1016/j.pain.2005.01.015. .
    1. O’Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics. 2009;27(2):95–112. doi: 10.2165/00019053-200927020-00002. .
    1. Shakespeare DT, Boggild M, Young C. Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst Rev. 2003;(4):CD001332. .
    1. Brouwer B, de Andrade VS. The effects of slow stroking on spasticity in patients with multiple sclerosis: a pilot study. Physiother Theory Pract. 1995;11(1):13–21. doi: 10.3109/09593989509022393.
    1. Nayak S, Matheis RJ, Schoenberger NE, Shiflett SC. Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil. 2003;17(2):181–191. doi: 10.1191/0269215503cr604oa. .
    1. Olsen SA. A review of complementary and alternative medicine (CAM) by people with multiple sclerosis. Occup Ther Int. 2009;16(1):57–70. doi: 10.1002/oti.266. .
    1. Hernandez-Reif M, Field T, Field T, Theakston H. Multiple sclerosis patients benefit from massage therapy. J Bodyw Mov Ther. 1998;2(3):168–174. doi: 10.1016/S1360-8592(98)80009-0. .
    1. Schroeder B, Premkumar K, Doig J. The effects of massage therapy on Multiple Sclerosis patients. BMC Complement Altern Med. 2012;12(Suppl 1):P225. doi: 10.1186/1472-6882-12-S1-P225. .
    1. Hernandez-Reif M, Field T, Largie S, Diego M, Manigat N, Seoanes J, et al. Cerebral palsy symptoms in children decreased following massage therapy. Early Child Dev Care. 2005;175(5):445–456. doi: 10.1080/0300443042000230546. .
    1. Norrbrink C, Lundeberg T. Acupuncture and massage therapy for neuropathic pain following spinal cord injury: an exploratory study. Acupunct Med. 2011;29(2):108–115. doi: 10.1136/aim.2010.003269. .
    1. Roberts L. Effects of patterns of pressure application on resting electromyography during massage. Int J Ther Massage Bodywork. 2011;4(1):4.
    1. Malila P, Seeda K, Machom S, Eungpinithpong W. Effects of Thai massage on spasticity in young people with cerebral palsy. J Med Assoc Thailand. 2015;98(Suppl 5):S92–S96. .
    1. Goldberg J, Sullivan SJ, Seaborne DE. The effect of two intensities of massage on H-reflex amplitude. Phys Ther. 1992;72(6):449–457. .
    1. Sunshine W, Field TM, Quintino O, Fierro K, Kuhn C, Burman I, et al. Fibromyalgia benefits from massage therapy and transcutaneous electrical stimulation. J Clin Rheumatol. 1996;2(1):18–22. doi: 10.1097/00124743-199602000-00005. .
    1. Field TM, Sunshine W, Hernandezreif M, Quintino O, Schanberg S, Kuhn C, et al. Massage therapy effects on depression and somatic symptoms in chronic fatigue syndrome. J Chronic Fatigue Syndr. 1997;3(3):43–51. doi: 10.1300/J092v03n03_03. .
    1. Manella C, Backus D. Gait characteristics, range of motion, and spasticity changes in response to massage in a person with incomplete spinal cord injury: case report. Int J Ther Massage Bodywork. 2011;4(1):28.
    1. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206–207. .
    1. Ritvo PG, Fischer JS, Miller DM, Andrews H, Paty DW, LaRocca NG. Multiple Sclerosis Quality of Life Inventory: a User’s Manual. New York: National Multiple Sclerosis Society; 1997.
    1. Potter K, Cohen ET, Allen DD, Bennett SE, Brandfass KG, Widener GL, et al. Outcome measures for individuals with multiple sclerosis: recommendations from the American Physical Therapy Association Neurology Section Task Force. Phys Ther. 2014;94(5):593–608. doi: 10.2522/ptj.20130149. .
    1. Schwid SR, Covington MMSB, Segal BM, Goodman AD. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev. 2002;39(2):211–224. .
    1. Flachenecker P, Kümpfel T, Kallmann B, Gottschalk M, Grauer O, Rieckmann P, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. 2002;8(6):523–526. doi: 10.1191/1352458502ms839oa. .
    1. Sherman KF, Dixon MW, Thompson D, Cherkin DC. Development of a taxonomy to describe massage treatments for musculoskeletal pain. BMC Complement Altern Med. 2006;6:24. doi: 10.1186/1472-6882-6-24.
    1. Archer P, Chandler C, Garbowski R, Lochhaas T, O’Hara J, Ribeiro C, et al. The Core: Entry-Level Analysis Project Report. 2013. [Accessed June 17, 2016]. .
    1. Eisen SV, Ranganathan G, Seal P, Spiro A., III Measuring clinically meaningful change following mental health treatment. J Behav Health Serv Res. 2007;34(3):272–289. doi: 10.1007/s11414-007-9066-2. .
    1. Cohen J. Statistical Power for the Behavioral Sciences. Hillsdale, NJ: Laurence Erlbaum and Associates; 1988.
    1. Induruwa I, Constantinescu CS, Gran B. Fatigue in multiple sclerosis—a brief review. J Neurol Sci. 2012;323(1):9–15. doi: 10.1016/j.jns.2012.08.007. .
    1. Steens A, Heersema DJ, Maurits NM, Renken RJ, Zijdewind I. Mechanisms underlying muscle fatigue differ between multiple sclerosis patients and controls: a combined electrophysiological and neuroimaging study. Neuroimage. 2012;59(4):3110–3118. doi: 10.1016/j.neuroimage.2011.11.038. .
    1. Krupp L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease [editorial] Mult Scler. 2006;12(4):367–368. doi: 10.1191/135248506ms1373ed. .
    1. Lerdal A, Celius EG, Krupp L, Dahl AA. A prospective study of patterns of fatigue in multiple sclerosis. Eur J Neurol. 2007;14(12):1338–1343. doi: 10.1111/j.1468-1331.2007.01974.x. .
    1. Giovannoni G. Multiple sclerosis related fatigue. J Neurol Neurosurg Psychiatry. 2006;77(1):2–3. doi: 10.1136/jnnp.2005.074948.
    1. Comi G, Leocani L, Rossi P, Colombo B. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol. 2001;248(3):174–179. doi: 10.1007/s004150170222. .
    1. Diego MA, Field T. Moderate pressure massage elicits a parasympathetic nervous system response. Int J Neurosci. 2009;119(5):630–638. doi: 10.1080/00207450802329605.
    1. Billhult A, Määttä S. Light pressure massage for patients with severe anxiety. Complement Ther Clin Pract. 2009;15(2):96–101. doi: 10.1016/j.ctcp.2008.10.003.
    1. Field T, Diego M, Hernandez-Reif M. Moderate pressure is essential for massage therapy effects. Int J Neurosci. 2010;120(5):381–385. doi: 10.3109/00207450903579475.
    1. Wood B, Van Der Mei IAF, Ponsonby AL, Pittas F, Quinn S, Dwyer T, et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler. 2013;19(2):217–224. doi: 10.1177/1352458512450351. .

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit